Recardio Inc., a late stage clinical-stage life science company developing regenerative therapies for cardiovascular diseases, announced that the FDA concurs with Recardio's pivotal Heal-MI Phase 3 trial design with Dutogliptin in Acute Myocardial Infarction.
Read MoreRecardio Inc., a clinical-stage life science company developing regenerative therapies for cardiovascular diseases, announced that the positive study results of Recardio's Phase 2 clinical study in Acute Myocardial Infarction were presented on Saturday, May 21, 2022, during the Latebreaker Session at the World Congress on Acute Heart Failure 2022 in Madrid.
Read MoreRecardio Inc., a life science company developing regenerative therapies for cardiovascular diseases, announced that its Phase 2 study of dutogliptin in combination with filgrastim in early recovery post-myocardial infarction is now enrolling and recruiting in all multiple European and U.S. centers.
Read More13th International Conference on Medical Regulation (IAMRA) in Association with the Dubai Health Regulation Conference 2018
Read MoreA common question is whether bones and teeth are made of the same tissues. While they are composed of many of the same elements, different cell types are responsible for their structure. Learn more and other vital facts in this press release.
Read MoreBioquark Inc., a cutting edge life sciences company focused on the development of a novel biologic portfolio of products, services, and technologies for complex regeneration, disease reversion, and aging in humans, is entering a collaboration with India's Revita Life Sciences to advance translational opportunities in spinal cord injury repair.
Read MoreCustomized Bioreactor Enables Stem Cell Scientists' Major Advance in Regenerative Medicine, Published in Nature Medicine
Read MoreMike Taylor, director of Nottingham Regeneration Ltd was joined by Matthew Hannah, a director of commercial property agent Innes England, last night (17 March) to deliver a presentation to a captivated audience on the market forces working to drive t
Read More